|9 Months Ended|
Sep. 30, 2020
|Share-based Payment Arrangement [Abstract]|
Note 3 - Share-Based Compensation
We account for share-based awards under the provisions of ASC 718, "Compensation—Stock Compensation." Accordingly, share-based compensation cost is measured at the grant date based on the fair value of the award and we expense these costs using the straight-line method over the requisite service period.
Share-based compensation expenses related to our restricted stock grants were $9.0 thousand and $18.0 thousand for the three months ended September 30, 2020 and 2019, respectively, and $23.0 thousand and $75.0 thousand for the nine months ended September 30, 2020 and 2019, respectively, which are reported as a separate line item in the condensed consolidated statements of changes in stockholders' deficit.
During the quarter ended September 30, 2020, pursuant to the 2015 Incentive Plan, we awarded an aggregate of 80,000 shares of restricted stock to the independent members of the Board of Directors, which are subject to a two-year cliff vesting, with 50% tranche on each anniversary. The grant date price per share was $0.10 for a total grant date fair value of $8.0 thousand. We also granted 100,000 shares of restricted stock to a third party consultant as part of the agreement for his services, which were fully vested at the grant date. The grant date price per share was $0.07 for a total grant date fair value of $6.8 thousand.
The entire disclosure for share-based payment arrangement.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef